Alnylam scientists harnessed RNA interference to build a platform that has delivered a proven class of medicines — and is now poised to reach new heights. An Alnylam scientist at work in the lab. Credit: Alnylam Pharmaceuticals, Inc. In drug discovery, very little of what’s learned from one project can typically be carried over to...
